Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

Background: Although non-vitamin K antagonist oral anticoagulants (NOACs) are recommended over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management, direct long-term head-to-head comparisons are lacking. Therefore, their risk-benefit profiles were investigated compared to VKAs and bet...

全面介紹

書目詳細資料

Principais autores:	Maxim Grymonprez, Tine L. De Backer, Xander Bertels, Stephane Steurbaut, Lies Lahousse
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2023-02-01
叢編:	Frontiers in Pharmacology
主題:	atrial fibrillation NOAC VKA anticoagulant thromboembolism bleeding
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1125576/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!